Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,237 public trials 1,175 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Kashiwa, Chiba, Japan
View Trial Details
Recruiting

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

NCT05889546

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Roudebush VA Medical Center Indianapolis, Indiana, United States
  • Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
View Trial Details
Recruiting

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

NCT07416474

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Affiliated to Chongqing University Chongqing, Chongqing Municipality, China
  • Chongqing Medical University First Affiliated Hospital Chongqing, Chongqing Municipality, China
View all 78 locations
View Trial Details
Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

NCT06706076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital - Arizona Phoenix, Arizona, United States
  • The Regents of the University of California - Irvine, CA Campus Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
View all 42 locations
View Trial Details
Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

NCT06692738

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Beverly Hills, California, United States
View all 312 locations
View Trial Details
Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

NCT06686771

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Saint Mary's Hospital and Regional Medical Center Grand Junction, Colorado, United States
View all 75 locations
View Trial Details
Recruiting

A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

NCT07699328

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Monash Medical Centre Clayton Clayton, Victoria, Australia
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • AP-HM Hôpital Nord Marseille, Bouches-du-Rhône, France
View all 29 locations
View Trial Details
Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

NCT06726148

Conditions
Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Breast Diseases, +14 more
Locations
  • University of California LA Los Angeles, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • WA Uni School Of Med St Louis, Missouri, United States
View all 33 locations
View Trial Details

Related conditions